{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_000302.3:c.391C>T",
          "cDNA Change": {
            "transcript": "NM_000302.3",
            "ref": "C",
            "alt": "T",
            "position": "391"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "W",
            "position": "131"
          },
          "Description in input context": "c.391C>T (p.Arg131Trp)"
        },
        {
          "HGVS": "NM_000302.3:c.1331G>A",
          "cDNA Change": {
            "transcript": "NM_000302.3",
            "ref": "G",
            "alt": "A",
            "position": "1331"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "H",
            "position": "444"
          },
          "Description in input context": "c.1331G>A (p.Arg444His)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005252"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with wild-type or mutant PARK2 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000302.3:c.391C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "PARK2 p.Arg131Trp showed reduced ubiquitin ligase activity compared to wild-type."
        },
        {
          "Variant": "NM_000302.3:c.1331G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "PARK2 p.Arg444His exhibited increased mitochondrial dysfunction and oxidative stress."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent transfections were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 construct was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Unpaired t-test with Bonferroni correction."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitin ligase activity > 80% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitin ligase activity < 50% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell Transfection",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells were transfected with PARK2 variants and analyzed for mitochondrial function."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000302.3:c.391C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "PARK2 p.Arg131Trp showed increased cell death in SH-SY5Y cells."
        },
        {
          "Variant": "NM_000302.3:c.1331G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "PARK2 p.Arg444His caused significant mitochondrial fragmentation in SH-SY5Y cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four independent transfections were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in quadruplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 construct was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-way ANOVA with post-hoc Tukey test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Mitochondrial membrane potential > 70% of control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Mitochondrial membrane potential < 40% of control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Patient-Derived Fibroblast Analysis",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Fibroblasts from Parkinson's patients",
        "Description": "Fibroblasts from patients with PARK2 mutations were analyzed for mitochondrial function."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000302.3:c.391C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Patient-derived fibroblasts with PARK2 p.Arg131Trp showed reduced mitochondrial complex I activity."
        },
        {
          "Variant": "NM_000302.3:c.1331G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Fibroblasts with PARK2 p.Arg444His exhibited increased levels of oxidative stress markers."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five patient-derived fibroblast lines were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Fibroblasts from healthy controls were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "No explicit negative control mentioned."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Mann-Whitney U test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Mitochondrial complex I activity > 85% of healthy controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Mitochondrial complex I activity < 60% of healthy controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}